Addison Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Addison Advisors's BMY Position: Q2 2026 in Review

Addison Advisors reduced its Bristol-Myers Squibb (BMY) stake by 87% in Q2 2026, selling an estimated $205K and leaving 549 shares worth $31.6K. The position accounts for 0.01% of the portfolio, ranked #290.

Addison Advisors first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $276K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Addison Advisors held 549 shares of Bristol-Myers Squibb worth $31.6K as of Q2 2026.
• Addison Advisors sold 3,568 Bristol-Myers Squibb shares in Q2 2026, an estimated $205K.
• Bristol-Myers Squibb made up 0.01% of Addison Advisors's portfolio in Q2 2026, its #290 holding.
• Addison Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
• Addison Advisors's Bristol-Myers Squibb position peaked at $276K in Q2 2022.
• 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.